ID   RCi002-A
AC   CVCL_9S43
SY   RCi92; FP5C-14; EM5-14; PFIZi033-A
DR   BioSamples; SAMEA3105892
DR   EBiSC; RCi002-A
DR   ECACC; 66540049
DR   hPSCreg; RCi002-A
DR   SKIP; SKIP002474
DR   Wikidata; Q54949499
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; 10597; SCN9A; Simple; p.Phe1460Val (c.4378T>G) (p.Phe1449Val, c.4345T>G); ClinVar=VCV000006352; Zygosity=Heterozygous (PubMed=27099175).
CC   Discontinued: ECACC; 66540049; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S44 ! RCi002-B
SX   Female
AG   <2Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 15
//
RX   PubMed=27099175; DOI=10.1126/scitranslmed.aad7653;
RA   Cao L.-S., McDonnell A., Nitzsche A., Alexandrou A., Saintot P.-P.,
RA   Loucif A.J.C., Brown A.R., Young G., Mis M., Randall A., Waxman S.G.,
RA   Stanley P., Kirby S., Tarabar S., Gutteridge A., Butt R.,
RA   McKernan R.M., Whiting P.J., Ali Z., Bilsland J., Stevens E.B.;
RT   "Pharmacological reversal of a pain phenotype in iPSC-derived sensory
RT   neurons and patients with inherited erythromelalgia.";
RL   Sci. Transl. Med. 8:335ra56.1-335ra56.12(2016).
//